Undalig, Ayalyn .
HRN: 26-99-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2025
CEFUROXIME 500MG (TAB)
04/19/2025
04/26/2025
ORAL
500mg
BID
S/P NSD With Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes